We are excited to inform you that under the guidance of the Food and Drug Administration and with the cellular, biological and tissue laboratory expertise of Vitti Labs , our Regenerative Medicine program, which utilizes biological allografts (i.e., stem cells), including cells derived from umbilical and placental tissues, is currently in the process of being restructured.